Local Anesthetics — MCQs

Local Anesthetics Indian Medical PG Practice Questions and MCQs

Question 41: Which amide local anesthetic is known to cause allergic reactions?

A. Lidocaine
B. Articaine (Correct Answer)
C. Benzocaine
D. Prilocaine

Explanation: **Explanation:** Local anesthetics (LAs) are chemically classified into two groups: **Esters** and **Amides**. While true allergic reactions to amides are extremely rare, **Articaine** is the unique exception among amides that can trigger such reactions. **Why Articaine is the correct answer:** Articaine is structurally unique because it is a "hybrid" molecule. Although it is classified as an **amide** (due to the linkage in its intermediate chain), its aromatic ring contains a **thiophene group** instead of a benzene ring, and it possesses an additional **ester side chain**. This ester group is metabolized by plasma carboxylesterases into articainic acid. Because it contains an ester component, it carries a higher risk of hypersensitivity reactions compared to pure amides, which are typically non-allergenic. **Analysis of Incorrect Options:** * **Lidocaine & Prilocaine:** These are pure amides. Allergic reactions to these are virtually non-existent; most "reactions" reported clinically are actually due to the preservative **Methylparaben** or systemic toxicity (LAST). * **Benzocaine:** This is a pure **ester** local anesthetic. Esters are frequently associated with allergic reactions because they are metabolized into **Para-aminobenzoic acid (PABA)**, a known potent allergen. However, the question specifically asks for an *amide* that causes allergy. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolism:** Articaine is the only amide metabolized primarily in the plasma (due to the ester group), giving it a very short half-life (~20 mins). * **Methemoglobinemia:** Prilocaine and Benzocaine are the high-yield triggers for methemoglobinemia (treated with Methylene Blue). * **Cardiotoxicity:** Bupivacaine is the most cardiotoxic LA (S-enantiomers like Levobupivacaine are safer). * **Rule of Thumb:** Amide LAs have two "i"s in their name (L**i**doca**i**ne), while Esters have only one (Proca**i**ne).

Question 42: Activity of all local anesthetic solutions is affected by the pH of the tissue or infection, except:

A. Propoxycaine
B. Benzocaine (Correct Answer)
C. Lidocaine
D. None of the above

Explanation: **Explanation:** The activity of most local anesthetics (LAs) is highly dependent on tissue pH because they are **weak bases**. In their standard form, they exist in an equilibrium between a lipid-soluble uncharged base (RN) and a water-soluble charged cation (RNH+). 1. **Why Benzocaine is the correct answer:** Benzocaine is a unique local anesthetic because it is an **exceptionally weak base** with a very low pKa (approx. 2.5). At physiological pH (7.4), it exists almost entirely in its **non-ionized (uncharged) form**. Unlike other LAs, it does not require a charged form to bind to the sodium channel receptor; it acts primarily by diffusing through the lipid membrane. Therefore, changes in tissue pH (such as the acidity found in infected tissues) do not significantly alter its ionization state or its clinical efficacy. 2. **Why other options are incorrect:** * **Lidocaine and Propoxycaine:** These are conventional LAs (Amides and Esters, respectively) with pKa values ranging from 7.7 to 9.1. In **acidic environments** (like infection/inflammation), the equilibrium shifts toward the **ionized form**. Since only the non-ionized form can cross the lipid nerve membrane, these drugs become trapped extracellularly, leading to a failure of anesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Action:** LAs block voltage-gated Na+ channels from the *inside* of the cell. * **Infection Paradox:** "Anesthesia does not work in pus" because the low pH decreases the fraction of non-ionized drug available to penetrate the nerve. * **Benzocaine Usage:** Due to its low solubility and pH independence, it is used exclusively as a **topical/surface anesthetic**. * **Side Effect:** Benzocaine is a classic cause of **methemoglobinemia** (treated with Methylene Blue).

Question 43: What is the concentration of epinephrine typically added to local anesthetic solutions?

A. 0.736111111
B. 1:10,000
C. 1:200,000 (Correct Answer)
D. 1.430555556

Explanation: **Explanation:** The addition of epinephrine (adrenaline) to local anesthetics (LA) serves as a **chemical tourniquet**. By inducing localized vasoconstriction, it decreases the rate of systemic absorption, which achieves three primary goals: prolonging the duration of action, decreasing systemic toxicity, and providing a bloodless surgical field. **Why 1:200,000 is Correct:** The standard clinical concentration for infiltration and regional blocks is **1:200,000** (equivalent to **5 mcg/mL**). This concentration provides an optimal balance between effective local vasoconstriction and minimal systemic side effects (such as tachycardia or hypertension). **Analysis of Incorrect Options:** * **1:10,000:** This is a highly concentrated solution used primarily in **cardiac arrest** (ACLS protocols). Using this with LA would cause severe tissue ischemia, necrosis, and significant systemic sympathomimetic toxicity. * **Options A & D:** These numerical values (0.736 and 1.430) are clinically irrelevant and do not represent standard pharmacological ratios or concentrations used in anesthesiology. **High-Yield NEET-PG Pearls:** * **Maximum Doses:** The addition of epinephrine increases the safe maximum dose of Lidocaine from **5 mg/kg to 7 mg/kg** and Bupivacaine from **2 mg/kg to 2.5–3 mg/kg**. * **Contraindications:** Avoid epinephrine-containing solutions in areas supplied by **end-arteries** (e.g., fingers, toes, nose, ears, and penis) due to the risk of gangrene. * **Calculation Tip:** To convert a ratio to mcg/mL, divide 1,000,000 by the ratio (e.g., 1,000,000 / 200,000 = 5 mcg/mL).

Question 44: Which afferent nerve fiber is affected first by local anesthesia?

A. Type A
B. Type II-B
C. Type C (Correct Answer)
D. Type II

Explanation: **Explanation:** The sensitivity of nerve fibers to local anesthetics (LAs) is determined by fiber diameter, myelination, and the frequency of firing. The correct answer is **Type C** fibers because they are the smallest in diameter and are unmyelinated, making them highly susceptible to the blockade of sodium channels. **Why Type C is Correct:** Local anesthetics work by blocking voltage-gated sodium channels from the inside. Smaller, unmyelinated fibers like **Type C (carrying slow pain and temperature)** have a smaller critical length (the length of the nerve that must be exposed to the drug to inhibit conduction). Because they lack a myelin sheath, the drug can access the axonal membrane along its entire length rather than just at the Nodes of Ranvier. **Why Other Options are Incorrect:** * **Type A:** These are large, myelinated fibers. While **Type A-delta** (small, myelinated) is often blocked very early (sometimes even before Type C in clinical practice due to its position in the nerve bundle), Type A-alpha and A-beta are the most resistant due to their large diameter and heavy myelination. * **Type II and II-B:** These classifications refer to sensory fibers (like those from muscle spindles). They are generally larger and myelinated, making them more resistant to local anesthetic blockade compared to the small Type C fibers. **NEET-PG High-Yield Pearls:** 1. **Order of Blockade (Clinical):** B fibers (Pre-ganglionic autonomic) > C and A-delta (Pain/Temp) > A-gamma (Muscle tone) > A-beta (Touch/Pressure) > A-alpha (Motor). 2. **The "B-Fiber" Exception:** Although Type C is the smallest, **Type B fibers** (small, myelinated) are often the very first to be blocked clinically because they are located peripherally in the nerve bundle. 3. **Recovery:** Recovery occurs in the reverse order (Motor recovers first, Autonomic last). 4. **Mechanism:** LAs are weak bases; the non-ionized form crosses the membrane, while the ionized form binds to the receptor.

Question 45: What is the action of toxic doses of local anesthetics on the CNS?

A. First stimulating the CNS followed by depression (Correct Answer)
B. First depressing the CNS followed by stimulation
C. Only depression of the CNS
D. Only stimulation of the CNS

Explanation: **Explanation:** The central nervous system (CNS) is highly sensitive to local anesthetic (LA) toxicity. The progression of symptoms follows a predictable biphasic pattern: **Initial Stimulation followed by Depression.** **1. Why Option A is Correct:** Local anesthetics work by blocking voltage-gated sodium channels. In the CNS, LAs initially block **inhibitory pathways** (specifically the inhibitory interneurons, such as GABAergic neurons). This "disinhibition" allows excitatory neurons to function unopposed, leading to signs of stimulation (agitation, tremors, and seizures). As the plasma concentration increases further, the LAs eventually block both inhibitory and **excitatory pathways**, resulting in generalized CNS depression (coma and respiratory arrest). **2. Why Other Options are Incorrect:** * **Option B:** This is physiologically incorrect; stimulation always precedes depression because inhibitory neurons are more sensitive to the block than excitatory ones. * **Option C & D:** These are incomplete. While depression (C) or stimulation (D) occurs, they represent different stages of the same toxicological spectrum. **Clinical Pearls for NEET-PG:** * **Early Signs of Toxicity:** Perioral numbness, metallic taste, tinnitus, and lightheadedness. * **The "Bupivacaine Exception":** While most LAs follow this CNS pattern, Bupivacaine is notoriously more **cardiotoxic** than neurotoxic. It can cause sudden refractory ventricular arrhythmias even before significant CNS symptoms appear. * **Management:** The definitive treatment for Local Anesthetic Systemic Toxicity (LAST) is **Intravenous Lipid Emulsion (20% Intralipid)**, which acts as a "lipid sink" to sequester the drug from tissues. * **Potentiation:** Hypercapnia (high $CO_2$) and acidosis lower the seizure threshold for local anesthetics.

Question 46: What is the safety profile of EMLA cream in newborns?

A. Contraindicated
B. Safe (Correct Answer)
C. Does not cause methemoglobinemia
D. Should be given in reduced doses

Explanation: **Explanation:** **EMLA (Eutectic Mixture of Local Anesthetics)** is a 1:1 oil-in-water emulsion of **2.5% Lidocaine and 2.5% Prilocaine**. 1. **Why it is Safe (Correct Answer):** Extensive clinical studies have established that EMLA is **safe** for use in full-term newborns (gestational age >37 weeks) for minor procedures like venipuncture, lumbar puncture, or circumcision. While there is a theoretical risk of methemoglobinemia due to the prilocaine component, when used at recommended doses and application times, it does not cause clinically significant elevation of methemoglobin levels. 2. **Analysis of Incorrect Options:** * **Contraindicated:** It is not contraindicated in newborns; it is widely used in neonatal intensive care units (NICUs). * **Does not cause methemoglobinemia:** This is technically incorrect. Prilocaine is metabolized into **o-toluidine**, which can oxidize hemoglobin to methemoglobin. While safe at low doses, the *potential* to cause methemoglobinemia exists, especially if used with other oxidizing agents. * **Should be given in reduced doses:** While dosage must be strictly monitored (max 1g over 10cm² for 1 hour), "Safe" is the more definitive clinical profile recognized in standard textbooks like Miller’s Anesthesia. **High-Yield Clinical Pearls for NEET-PG:** * **Composition:** 2.5% Lidocaine + 2.5% Prilocaine. The melting point of the mixture is lower than the individual components (Eutectic property), allowing it to exist as an oil at room temperature, enhancing skin penetration. * **Application Time:** Requires **45–60 minutes** under an occlusive dressing to achieve effective analgesia (depth of 3–5 mm). * **Caution:** Use with caution in infants <3 months or those taking methemoglobin-inducing drugs (e.g., sulfonamides, phenytoin, phenobarbital). * **Contraindication:** Do not apply to broken skin, mucous membranes, or near the eyes/ears (ototoxicity risk).

Question 47: What is the effect of chilling in refrigeration analgesia?

A. Interference with conduction of nerve impulse
B. Reduction of metabolic rate and oxygen requirement
C. Inhibition of bacterial growth and infection
D. All of the above (Correct Answer)

Explanation: **Explanation:** Refrigeration analgesia (cryoanalgesia) involves the application of extreme cold to tissues to produce a localized anesthetic effect. This technique utilizes several physiological changes induced by low temperatures: 1. **Interference with Nerve Conduction:** Cold temperatures decrease the velocity of nerve impulses. When the temperature drops sufficiently, it leads to a complete reversible conduction block in sensory nerve fibers, effectively preventing pain signals from reaching the brain. 2. **Reduction of Metabolic Rate:** According to the *Van't Hoff rule*, chemical reactions slow down with decreasing temperature. Chilling significantly reduces the metabolic rate and oxygen demand of the tissues. This provides a protective effect against ischemia during procedures where blood flow might be compromised. 3. **Inhibition of Bacterial Growth:** Low temperatures create an environment hostile to bacterial multiplication and enzymatic activity, thereby reducing the risk of wound infection and slowing the progression of existing gangrene. **Why "All of the above" is correct:** Since chilling simultaneously numbs the area (Option A), protects the tissue from hypoxic damage (Option B), and provides an antiseptic-like effect (Option C), all three mechanisms contribute to the clinical utility of refrigeration analgesia. **High-Yield Clinical Pearls for NEET-PG:** * **Historical Context:** Historically used for limb amputations in patients too unstable for general anesthesia (e.g., severe gangrene with sepsis). * **Mechanism:** It primarily affects myelinated A-delta and C-fibers. * **Modern Use:** Today, cryoanalgesia is more commonly used in pain clinics (cryoneurolysis) for chronic pain conditions like intercostal neuralgia or post-herpetic neuralgia. * **Pre-requisite:** For surgical anesthesia, the tissue temperature usually needs to be lowered to approximately 5°C to 10°C.

Question 48: Which of the following is NOT used for surface anesthesia?

A. Lignocaine
B. Procaine (Correct Answer)
C. Tetracaine
D. Benzocaine

Explanation: **Explanation:** The effectiveness of a local anesthetic (LA) for surface (topical) anesthesia depends on its ability to penetrate mucous membranes or skin. **Why Procaine is the Correct Answer:** Procaine is an ester-linked local anesthetic with **very low lipid solubility** and poor penetrative capacity. Because it cannot effectively cross mucosal barriers, it is virtually ineffective when applied topically. It is primarily used for infiltration anesthesia and was historically used for spinal anesthesia, but it has no role in surface anesthesia. **Analysis of Incorrect Options:** * **Lignocaine (Lidocaine):** The most versatile LA. It has excellent lipid solubility and is widely used for surface anesthesia in various forms (e.g., 2% jelly for catheterization, 4% topical solution for airway blocks, and 10% spray for dental procedures). * **Tetracaine (Amethocaine):** A potent ester LA with high lipid solubility. It is highly effective for surface anesthesia, particularly in ophthalmology (eye drops) and for topical anesthesia of the tracheobronchial tree. * **Benzocaine:** Due to its very low pKa, it exists almost entirely in the unionized form. This makes it highly lipid-soluble but poorly water-soluble. It is used exclusively for surface anesthesia (e.g., lozenges for sore throats, topical gels for mouth ulcers) because it is too toxic for injection. **High-Yield NEET-PG Pearls:** * **Cocaine** is the only naturally occurring local anesthetic and possesses intrinsic vasoconstrictive properties, making it excellent for topical use in ENT surgeries. * **EMLA (Eutectic Mixture of Local Anesthetics):** A 1:1 mixture of 2.5% Lignocaine and 2.5% Prilocaine used to anesthetize intact skin. * **Potency & Duration:** Both are directly proportional to **lipid solubility**. * **Onset of Action:** Inversely proportional to the **pKa** (lower pKa = faster onset).

Question 49: What is the maximum dose of lidocaine without epinephrine that can be safely administered to a 60 kg adult?

A. 500 mg
B. 300 mg (Correct Answer)
C. 400 mg
D. 600 mg

Explanation: **Explanation:** The maximum safe dose of local anesthetics is calculated based on the patient’s body weight to prevent **Local Anesthetic Systemic Toxicity (LAST)**. 1. **Why Option B is Correct:** For **Lidocaine (Lignocaine) without epinephrine (plain)**, the standard maximum recommended dose is **4 mg/kg to 5 mg/kg**. * Calculation: $5\text{ mg/kg} \times 60\text{ kg} = 300\text{ mg}$. * In clinical practice and for exams, 300 mg is the recognized ceiling dose for a 60 kg adult to avoid CNS and cardiovascular toxicity. 2. **Why Other Options are Incorrect:** * **Option A (500 mg):** This exceeds the safe limit for plain lidocaine. 500 mg (or 7 mg/kg) is the maximum dose only when lidocaine is combined **with epinephrine**, as the vasoconstrictor slows systemic absorption. * **Options C & D (400 mg & 600 mg):** These doses significantly exceed the 5 mg/kg threshold for plain lidocaine and pose a high risk of seizures and arrhythmias. **High-Yield Clinical Pearls for NEET-PG:** * **Lidocaine with Epinephrine:** Max dose is **7 mg/kg** (up to 500 mg). * **Bupivacaine:** Max dose is **2 mg/kg** (plain) and **2.5–3 mg/kg** (with epinephrine). It is more cardiotoxic than lidocaine. * **Toxicity Management:** The specific antidote for LAST is **20% Intralipid (Lipid Emulsion Therapy)**. * **Order of Toxicity:** CNS symptoms (perioral numbness, metallic taste, seizures) usually precede Cardiovascular collapse (except with Bupivacaine, where they may occur simultaneously).

Question 50: Which of the following does NOT affect the duration of action of local anesthesia?

A. Protein binding capacity of the local anesthetic
B. Addition of a vasoconstrictor
C. Vasodilator activity of the local anesthetic
D. Non-nervous tissue diffusibility (Correct Answer)

Explanation: The duration of action of a local anesthetic (LA) is primarily determined by how long the drug remains in contact with the nerve membrane. This is governed by its chemical properties and local blood flow. ### **Why "Non-nervous tissue diffusibility" is the Correct Answer** Non-nervous tissue diffusibility (or the **pKa/Ionization constant**) primarily determines the **onset of action**, not the duration. A drug’s ability to diffuse through non-neural tissues relates to how quickly it reaches the target nerve. Once the drug is at the nerve, its persistence there (duration) depends on binding and vascular removal, not initial tissue diffusion. ### **Analysis of Incorrect Options** * **Protein Binding (Option A):** This is the **most important** determinant of duration. LAs bind to proteins (like albumin and alpha-1 acid glycoprotein) in the sodium channel. High protein binding (e.g., Bupivacaine, Ropivacaine) results in a longer duration of action compared to low protein binding (e.g., Lidocaine). * **Addition of a Vasoconstrictor (Option B):** Adding Epinephrine causes local vasoconstriction, which decreases the rate of systemic absorption (washout). This keeps the LA at the nerve site longer, thereby increasing the duration. * **Vasodilator Activity (Option C):** Most LAs (except Cocaine and Ropivacaine) are intrinsic vasodilators. Higher intrinsic vasodilatory activity increases blood flow, leading to faster systemic absorption and a **shorter** duration of action. ### **High-Yield NEET-PG Pearls** * **Potency** is determined by **Lipid Solubility**. * **Onset of Action** is determined by **pKa** (Lower pKa = more non-ionized drug = faster onset). * **Duration of Action** is determined by **Protein Binding**. * **Bupivacaine** has the highest protein binding (~95%) and thus a very long duration. * **Cocaine** is the only LA that causes significant vasoconstriction.

Practice by Chapter

Chemistry and Mechanism of Action

Practice Questions

Pharmacokinetics of Local Anesthetics

Practice Questions

Amide Local Anesthetics

Practice Questions

Ester Local Anesthetics

Practice Questions

Clinical Uses of Local Anesthetics

Practice Questions

Toxicity of Local Anesthetics

Practice Questions

Management of Local Anesthetic Systemic Toxicity

Practice Questions

Adjuvants to Local Anesthetics

Practice Questions

Maximum Safe Doses

Practice Questions

Local Anesthetics in Special Populations

Practice Questions

Allergic Reactions to Local Anesthetics

Practice Questions

Future Developments in Local Anesthetics

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free